BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6:2364-2373. [PMID: 21852664 DOI: 10.2215/cjn.02180311] [Cited by in Crossref: 336] [Cited by in F6Publishing: 364] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Shi M, Yang A, Fan B, Tam CH, Lau E, Luk AO, Kong AP, Ma RC, Chan JC, Chow E. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995–2019). Diabetes Research and Clinical Practice 2022;193:110118. [DOI: 10.1016/j.diabres.2022.110118] [Reference Citation Analysis]
2 Liu P, Tang L, Fang J, Chen C, Liu X. Association between recovery/occurrence of metabolic syndrome and rapid estimated glomerular filtration rate decline in middle-aged and older populations: evidence from the China Health and Retirement Longitudinal Study. BMJ Open 2022;12:e059504. [PMID: 36261237 DOI: 10.1136/bmjopen-2021-059504] [Reference Citation Analysis]
3 Li Q, Wang P, Li G, Chang Y, Guo X, Sun Y, Zhang X. Using the changes of several simple anthropometric indices to predict the occurrence of metabolic syndrome: Findings from medically under-resourced communities in rural China. Front Endocrinol 2022;13:1014541. [DOI: 10.3389/fendo.2022.1014541] [Reference Citation Analysis]
4 Kuma A, Mafune K, Uchino B, Ochiai Y, Miyamoto T, Kato A. Potential link between high FIB-4 score and chronic kidney disease in metabolically healthy men. Sci Rep 2022;12:16638. [PMID: 36198747 DOI: 10.1038/s41598-022-21039-0] [Reference Citation Analysis]
5 Gorgojo-martinez JJ, Brito-sanfiel M, Antón-bravo T, Galdón Sanz-pastor A, Wong-cruz J, Gargallo Fernández MA. Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study. JCM 2022;11:5622. [DOI: 10.3390/jcm11195622] [Reference Citation Analysis]
6 Fernández-Verdejo R, Galgani JE. Exploring the sequential accumulation of metabolic syndrome components in adults. Sci Rep 2022;12:15925. [PMID: 36151232 DOI: 10.1038/s41598-022-19510-z] [Reference Citation Analysis]
7 Soriano-Moreno DR, Fernandez-Morales J, Medina-Ramirez SA, Coico-Lama AH, Soriano-Moreno AN, Zafra-Tanaka JH. Metabolic Syndrome and Risk of Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Cardiol Rev 2022. [PMID: 36129333 DOI: 10.1097/CRD.0000000000000470] [Reference Citation Analysis]
8 Weldegiorgis M, Woodward M. Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02932-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kuma A, Kato A. Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population. Nutrients 2022;14:3787. [DOI: 10.3390/nu14183787] [Reference Citation Analysis]
10 Chocair PR, de Menezes Neves PDM, Sato VAH, Mohrbacher S, Oliveira ÉS, Pereira LVB, Bales AM, da Silva FP, Duley JA, Cuvello-neto AL. Proposal for standardizing normal insulin ranges in Brazilian patients and a new classification of metabolic syndrome. Front Med 2022;9. [DOI: 10.3389/fmed.2022.984001] [Reference Citation Analysis]
11 Ahluwalia N, Raghavan R, Zhang G, Talegawkar SA, Jacques PF. Vitamin D status and prevalence of metabolic syndrome by race and Hispanic origin in US adults: findings from the 2007–2014 NHANES. The American Journal of Clinical Nutrition 2022. [DOI: 10.1093/ajcn/nqac234] [Reference Citation Analysis]
12 Hung C, Zhen Y, Niu S, Lin K, Lin HY, Lee J, Chang J, Kuo I. Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1–4 Patients. Biomedicines 2022;10:1858. [DOI: 10.3390/biomedicines10081858] [Reference Citation Analysis]
13 Zhang Y, Li B, Liu Y, Gao W, Chen K, Wang A, Tang X, Yan L, Luo Z, Qin G, Chen L, Wan Q, Gao Z, Wang W, Ning G, Mu Y. Association between metabolic phenotype and urinary albumin-creatinine ratio in Chinese community adults: A cross-sectional study. J Diabetes 2022;14:541-50. [PMID: 36040203 DOI: 10.1111/1753-0407.13302] [Reference Citation Analysis]
14 Kim JY, Yu JH, Kang SH, Lee JG, Cheon J, Kang SG. The effect of metabolic risk factors on urinary stone composition: An observational study. Medicine (Baltimore) 2022;101:e29622. [PMID: 35838990 DOI: 10.1097/MD.0000000000029622] [Reference Citation Analysis]
15 Richardson KA, Richardson LT, Bowden RG. Association of High-Density Lipoprotein Cholesterol, Renal Function, and Metabolic Syndrome: An Assessment of the 2013–2018 National Health and Nutrition Examination Surveys. Kidney and Dialysis 2022;2:419-432. [DOI: 10.3390/kidneydial2030037] [Reference Citation Analysis]
16 Frutos MÁ, Crespo M, Valentín MDLO, Alonso-melgar Á, Alonso J, Fernández C, García-erauzkin G, González E, González–rinne AM, Guirado L, Gutiérrez-dalmau A, Huguet J, Moral JLLD, Musquera M, Paredes D, Redondo D, Revuelta I, Hofstadt CJV, Alcaraz A, Alonso-hernández Á, Alonso M, Bernabeu P, Bernal G, Breda A, Cabello M, Caro-oleas JL, Cid J, Diekmann F, Espinosa L, Facundo C, García M, Gil-vernet S, Lozano M, Mahillo B, Martínez MJ, Miranda B, Oppenheimer F, Palou E, Pérez-saez MJ, Peri L, Rodríguez O, Santiago C, Tabernero G, Hernández D, Domínguez-gil B, Pascual J. Recommendations for living donor renal transplantation. Nefrología (English Edition) 2022. [DOI: 10.1016/j.nefroe.2022.07.001] [Reference Citation Analysis]
17 Lin L, Tan W, Pan X, Tian E, Wu Z, Yang J. Metabolic Syndrome-Related Kidney Injury: A Review and Update. Front Endocrinol 2022;13:904001. [DOI: 10.3389/fendo.2022.904001] [Reference Citation Analysis]
18 Fu Y, Xu Z, Zhao M, Xu K. The Association Between Smoking and Renal Function in People Over 20 Years Old. Front Med 2022;9:870278. [DOI: 10.3389/fmed.2022.870278] [Reference Citation Analysis]
19 Shan X, Zhao X, Li S, Song P, Man Q, Liu Z, Hu Y, Yang L. Association of Serum 25(OH)D with Metabolic Syndrome in Chinese Women of Childbearing Age. Nutrients 2022;14:2301. [PMID: 35684100 DOI: 10.3390/nu14112301] [Reference Citation Analysis]
20 Lee S, Lai H, Chua YJ, Wang MX, Lee G. Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis. Front Med 2022;9:880749. [DOI: 10.3389/fmed.2022.880749] [Reference Citation Analysis]
21 Frutos MÁ, Crespo M, Valentín MDLO, Alonso-melgar Á, Alonso J, Fernández C, García-erauzkin G, González E, González-rinne AM, Guirado L, Gutiérrez-dalmau A, Huguet J, López del Moral JL, Musquera M, Paredes D, Redondo D, Revuelta I, Van-der Hofstadt CJ, Alcaraz A, Alonso-hernández Á, Alonso M, Bernabeu P, Bernal G, Breda A, Cabello M, Caro-oleas JL, Cid J, Diekmann F, Espinosa L, Facundo C, García M, Gil-vernet S, Lozano M, Mahillo B, Martínez MJ, Miranda B, Oppenheimer F, Palou E, Pérez-saez MJ, Peri L, Rodríguez O, Santiago C, Tabernero G, Hernández D, Domínguez-gil B, Pascual J. Recomendaciones para el trasplante renal de donante vivo. Nefrología 2022;42:1-128. [DOI: 10.1016/j.nefro.2021.10.002] [Reference Citation Analysis]
22 Soohoo M, Hashemi L, Hsiung JT, Moradi H, Budoff MJ, Kovesdy CP, Kalantar-Zadeh K, Streja E. Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans. Nephron 2022;:1-12. [PMID: 35354153 DOI: 10.1159/000522388] [Reference Citation Analysis]
23 Baratta F, D’erasmo L, Di Costanzo A, Umbro I, Pastori D, Angelico F, Del Ben M. Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2022;10:720. [DOI: 10.3390/biomedicines10030720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Mazidi M, Kengne AP, Siervo M, Kirwan R. Association of Dietary Intakes and Genetically Determined Serum Concentrations of Mono and Poly Unsaturated Fatty Acids on Chronic Kidney Disease: Insights from Dietary Analysis and Mendelian Randomization. Nutrients 2022;14:1231. [PMID: 35334888 DOI: 10.3390/nu14061231] [Reference Citation Analysis]
25 Lu Y, Nyunt MSZ, Gao Q, Gwee X, Chua DQ, Yap KB, Pan F, Ng TP. Malnutrition Risk and Kidney Function and Decline in Community-Dwelling Older Adults. J Ren Nutr 2022:S1051-2276(21)00229-6. [PMID: 35300925 DOI: 10.1053/j.jrn.2021.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Jung CY, Yoo TH. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease. Diabetes Metab J 2022;46:181-97. [PMID: 35385633 DOI: 10.4093/dmj.2021.0329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
27 El Gaamouch F, Lin H, Wang Q, Zhao W, Pan J, Liu K, Wong J, Wu C, Yuan C, Cheng H, Qin W, Hao K, Zhang B, Wang J. Peripheral and cognitive benefits of physical exercise in a mouse model of midlife metabolic syndrome. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07252-x] [Reference Citation Analysis]
28 Kuma A, Mafune K, Uchino B, Ochiai Y, Enta K, Kato A. Development of chronic kidney disease influenced by serum urate and body mass index based on young-to-middle-aged Japanese men: a propensity score-matched cohort study. BMJ Open 2022;12:e049540. [PMID: 35131815 DOI: 10.1136/bmjopen-2021-049540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhao L, Zou Y, Bai L, Zhou L, Ren H, Wu Y, Wang Y, Li S, Su Q, Tang L, Zhao Y, Xu H, Li L, Chai Z, Cooper ME, Tong N, Zhang J, Liu F. Prognostic value of metabolic syndrome in renal structural changes in type 2 diabetes. Int Urol Nephrol 2022. [PMID: 35043385 DOI: 10.1007/s11255-021-03051-x] [Reference Citation Analysis]
30 Kramer HJ, Joshi S. Metabolic syndrome and kidney disease. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00028-8] [Reference Citation Analysis]
31 Friedman AN. Nutritional and metabolic management of obesity and the metabolic syndrome in patients with chronic kidney disease. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00007-0] [Reference Citation Analysis]
32 Wang P, Li Q, Guo X, Zhou Y, Li Z, Yang H, Yu S, Sun G, Zheng L, Sun Y, Zhang X. Usefulness of metabolic score for insulin resistance index in estimating the risk of mildly reduced estimate glomerular filtration rate: a cross-sectional study of rural population in China. BMJ Open 2021;11:e050907. [PMID: 34916312 DOI: 10.1136/bmjopen-2021-050907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kotsis V, Martinez F, Trakatelli C, Redon J. Impact of Obesity in Kidney Diseases. Nutrients 2021;13:4482. [PMID: 34960033 DOI: 10.3390/nu13124482] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
34 Mariano F, De Biase C, Hollo Z, Deambrosis I, Davit A, Mella A, Bergamo D, Maffei S, Rumbolo F, Papaleo A, Stella M, Biancone L. Long-Term Preservation of Renal Function in Septic Shock Burn Patients Requiring Renal Replacement Therapy for Acute Kidney Injury. J Clin Med 2021;10:5760. [PMID: 34945056 DOI: 10.3390/jcm10245760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Cheung A, Ahmed A. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks. Clin Exp Gastroenterol 2021;14:457-65. [PMID: 34819740 DOI: 10.2147/CEG.S226130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Wang X, Wang H, Li J, Gao X, Han Y, Teng W, Shan Z, Lai Y. Combined Effects of Dyslipidemia and High Adiposity on the Estimated Glomerular Filtration Rate in a Middle-Aged Chinese Population. Diabetes Metab Syndr Obes 2021;14:4513-22. [PMID: 34785920 DOI: 10.2147/DMSO.S337190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Mazidi M, Kirwan R, Davies IG. Genetically determined blood lead is associated with reduced renal function amongst individuals with type 2 diabetes mellitus: insight from Mendelian Randomisation. J Mol Med (Berl) 2021. [PMID: 34661687 DOI: 10.1007/s00109-021-02152-5] [Reference Citation Analysis]
38 Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease. Am J Nephrol 2021;52:666-72. [PMID: 34569517 DOI: 10.1159/000518111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Wiese ML, Aghdassi AA, Lerch MM, Steveling A. Excess Body Weight and Pancreatic Disease. Visc Med 2021;37:281-6. [PMID: 34540944 DOI: 10.1159/000517147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kim BY, Choi DH, Jung CH, Mok JO, Kim CH. Associations between obesity, weight change and decreased renal function in Korean type 2 diabetic patients: a longitudinal follow-up study. BMC Endocr Disord 2021;21:188. [PMID: 34535101 DOI: 10.1186/s12902-021-00853-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 DeFronzo RA, Abdul-Ghani M. Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney. Diabetes Spectr 2021;34:225-34. [PMID: 34511848 DOI: 10.2337/ds20-0071] [Reference Citation Analysis]
42 Adair KE, Bowden RG, Funderburk LK, Forsse JS, Ylitalo KR. Metabolic Health, Obesity, and Renal Function: 2013-2018 National Health and Nutrition Examination Surveys. Life (Basel) 2021;11:888. [PMID: 34575037 DOI: 10.3390/life11090888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Hakroush S, Tampe D, Korsten P, Tampe B. Impact of the COVID-19 Pandemic on Kidney Diseases Requiring Renal Biopsy: A Single Center Observational Study. Front Physiol 2021;12:649336. [PMID: 34305628 DOI: 10.3389/fphys.2021.649336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
44 Kao TW, Huang CC. Recent Progress in Metabolic Syndrome Research and Therapeutics. Int J Mol Sci 2021;22:6862. [PMID: 34202257 DOI: 10.3390/ijms22136862] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
45 Kim H, Park S, Kwon SH, Jeon JS, Han DC, Noh H. Impaired fasting glucose and development of chronic kidney disease in non-diabetic population: a Mendelian randomization study. BMJ Open Diabetes Res Care 2020;8:e001395. [PMID: 32457053 DOI: 10.1136/bmjdrc-2020-001395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Sheu WHH, Chan SP, Matawaran BJ, Deerochanawong C, Mithal A, Chan J, Suastika K, Khoo CM, Nguyen HM, Linong J, Luk A, Yoon KH. Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations. Diabetes Metab J 2020;44:11-32. [PMID: 32097996 DOI: 10.4093/dmj.2019.0208] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
47 Reynolds EL, Akinci G, Banerjee M, Looker HC, Patterson A, Nelson RG, Feldman EL, Callaghan BC. The determinants of complication trajectories in American Indians with type 2 diabetes. JCI Insight 2021;6:146849. [PMID: 34027894 DOI: 10.1172/jci.insight.146849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lambert DC, Abramowitz MK. Obesity and the Risk of Low Bicarbonate: A Cohort Study. Kidney Med 2021;3:498-506.e1. [PMID: 34401717 DOI: 10.1016/j.xkme.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Ebzeeva EY, Ostroumova OD, Batyukina SV, Shatalova NA, Doldo NM, Romanovsky RR. Possibilities of using fosinopril in treatment of patients with chronic kidney disease in combination with cardiovascular diseases and diabetes mellitus. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-1-17-25] [Reference Citation Analysis]
50 Pal K, Horsfall L, Sharma M, Nazareth I, Petersen I. Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009-2018: a retrospective cohort study. BMJ Open Diabetes Res Care 2021;9:e001989. [PMID: 33741554 DOI: 10.1136/bmjdrc-2020-001989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
51 Karahan Yılmaz S, Mertoğlu C, Ayaz A. Assessment of Relationship Between Serum Vitamin D Levels and Metabolic Syndrome Components in Hemodialysis Patients. Galician med j 2021;28:E202113. [DOI: 10.21802/gmj.2021.1.3] [Reference Citation Analysis]
52 Koh ES, Do Han K, Kim MK, Kim ES, Lee MK, Nam GE, Hong OK, Kwon HS. Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study. Sci Rep 2021;11:1957. [PMID: 33479302 DOI: 10.1038/s41598-021-81396-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
53 Zhang Y, Wu T, Xie J, Yan L, Guo X, Xu W, Wang L. Effects of metabolic syndrome on renal function after radical nephrectomy in patients with renal cell carcinoma. Int Urol Nephrol 2021. [PMID: 33459957 DOI: 10.1007/s11255-020-02759-6] [Reference Citation Analysis]
54 Syauqy A, Hsu CY, Lee HA, Rau HH, Chao JC. Association between Dietary Patterns and Kidney Function Parameters in Adults with Metabolic Syndrome: A Cross-Sectional Study. Nutrients 2020;13:E40. [PMID: 33374257 DOI: 10.3390/nu13010040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
55 Luo W, Zhou Y, Gao C, Yan P, Xu L. Urolithiasis, Independent of Uric Acid, Increased Risk of Coronary Artery and Carotid Atherosclerosis: A Meta-Analysis of Observational Studies. Biomed Res Int 2020;2020:1026240. [PMID: 32149075 DOI: 10.1155/2020/1026240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Kabeer MA, Cross J, Hamilton G, Rashid ST. Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy. Angiology 2021;72:274-8. [PMID: 33228378 DOI: 10.1177/0003319720969536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
57 Juszczak F, Caron N, Mathew AV, Declèves AE. Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease. Int J Mol Sci 2020;21:E7994. [PMID: 33121167 DOI: 10.3390/ijms21217994] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
58 Kurniawan AL, Hsu CY, Lee HA, Rau HH, Paramastri R, Syauqy A, Chao JC. Comparing two methods for deriving dietary patterns associated with risk of metabolic syndrome among middle-aged and elderly Taiwanese adults with impaired kidney function. BMC Med Res Methodol 2020;20:255. [PMID: 33054793 DOI: 10.1186/s12874-020-01142-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz E. Chronic Microvascular Complications in Prediabetic States-An Overview. J Clin Med 2020;9:E3289. [PMID: 33066307 DOI: 10.3390/jcm9103289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
60 Guligowska A, Corsonello A, Pigłowska M, Roller-Wirnsberger R, Wirnsberger G, Ärnlöv J, Carlsson AC, Tap L, Mattace-Raso F, Formiga F, Moreno-Gonzalez R, Freiberger E, Sieber C, Gregorio PG, Martínez SL, Artzi-Medvedik R, Yehoshua I, Fabbietti P, Lattanzio F, Kostka T; SCOPE investigators. Association between kidney function, nutritional status and anthropometric measures in older people : The Screening for CKD among Older People across Europe (SCOPE) study. BMC Geriatr 2020;20:366. [PMID: 33008315 DOI: 10.1186/s12877-020-01699-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
61 Sun J, Su H, Lou Y, Wang M. Association Between Serum Albumin Level and All-Cause Mortality in Patients With Chronic Kidney Disease: A Retrospective Cohort Study. Am J Med Sci 2021;361:451-60. [PMID: 32958160 DOI: 10.1016/j.amjms.2020.07.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Moon H, Ko HJ, Kim AS. Hyperhomocysteinemia Concurrent with Metabolic Syndrome Is Independently Associated with Chronic Kidney Disease among Community-Dwelling Adults in an Urban Korean Population. Int J Environ Res Public Health 2020;17:E6810. [PMID: 32961936 DOI: 10.3390/ijerph17186810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Cheng HS, Goh BH, Phang SCW, Amanullah MM, Ton SH, Palanisamy UD, Abdul Kadir K, Tan JBL. Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats. Nutrition 2020;79-80:110973. [PMID: 32916379 DOI: 10.1016/j.nut.2020.110973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Liu L, Gao B, Wang J, Yang C, Wu S, Wu Y, Chen S, Li Q, Zhang H, Wang G, Chen M, Zhao MH, Zhang L. Clinical significance of single and persistent elevation of serum high-sensitivity C-reactive protein levels for prediction of kidney outcomes in patients with impaired fasting glucose or diabetes mellitus. J Nephrol 2021;34:1179-88. [PMID: 32880885 DOI: 10.1007/s40620-020-00848-4] [Reference Citation Analysis]
65 Kelly JT, Su G, Zhang, Qin X, Marshall S, González-Ortiz A, Clase CM, Campbell KL, Xu H, Carrero JJ. Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol 2021;32:239-53. [PMID: 32868398 DOI: 10.1681/ASN.2020030384] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
66 Sánchez-Solís CN, Hernández-Fragoso H, Aburto-Luna V, Olivier CB, Diaz A, Brambila E, Treviño S. Kidney Adaptations Prevent Loss of Trace Elements in Wistar Rats with Early Metabolic Syndrome. Biol Trace Elem Res 2021;199:1941-53. [PMID: 32789645 DOI: 10.1007/s12011-020-02317-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Chuang HH, Lin RH, Li WC, Yeh WC, Lin YA, Chen JY. High-Sensitivity C-Reactive Protein Elevation Is Independently Associated with Subclinical Renal Impairment in the Middle-Aged and Elderly Population-A Community-Based Study in Northern Taiwan. Int J Environ Res Public Health. 2020;17. [PMID: 32823680 DOI: 10.3390/ijerph17165878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 Piantedosi D, Palatucci AT, Giovazzino A, Ruggiero G, Rubino V, Musco N, Carriero F, Farina F, Attia YAEW, Terrazzano G, Lombardi P, Cortese L. Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs. Front Vet Sci 2020;7:398. [PMID: 32851001 DOI: 10.3389/fvets.2020.00398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
69 Tanaka S, Watanabe H, Nakano T, Imafuku T, Kato H, Tokumaru K, Arimura N, Enoki Y, Maeda H, Tanaka M, Matsushita K, Fukagawa M, Maruyama T. Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase. Toxins (Basel) 2020;12:E502. [PMID: 32764271 DOI: 10.3390/toxins12080502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
70 Kim Y, Park CW. Can management of the components of metabolic syndrome modify the course of chronic kidney disease? Kidney Res Clin Pract 2020;39:118-20. [PMID: 32522892 DOI: 10.23876/j.krcp.20.066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Yoshioka M, Okamoto Y, Murata M, Fukui M, Yanagisawa S, Shirayama Y, Nagai K, Hinode D. Association between Oral Health Status and Diabetic Nephropathy-Related Indices in Japanese Middle-Aged Men. J Diabetes Res 2020;2020:4042129. [PMID: 32587866 DOI: 10.1155/2020/4042129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Xie Z, Li Z, Dong W, Chen Y, Li R, Wu Y, Lin T, Tao Y, Liang H, Wang W, Liu S, Ye Z, Shi W, Liang X. Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study. Clin Cardiol 2020;43:949-56. [PMID: 32469090 DOI: 10.1002/clc.23388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
73 Lutz SM, Hokanson JE. The Use of Mendelian Randomization to Determine the Role of Metabolic Traits on Urinary Albumin-to-Creatinine Ratio. Diabetes 2020;69:862-3. [PMID: 32312903 DOI: 10.2337/dbi19-0034] [Reference Citation Analysis]
74 Simeoni M, Borrelli S, Garofalo C, Fuiano G, Esposito C, Comi A, Provenzano M. Atherosclerotic-nephropathy: an updated narrative review. J Nephrol 2021;34:125-36. [PMID: 32270411 DOI: 10.1007/s40620-020-00733-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
75 Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol 2020;72:785-801. [PMID: 32059982 DOI: 10.1016/j.jhep.2020.01.013] [Cited by in Crossref: 150] [Cited by in F6Publishing: 143] [Article Influence: 75.0] [Reference Citation Analysis]
76 Zhang L, Zhu XY, Zhao Y, Eirin A, Liu L, Ferguson CM, Tang H, Lerman A, Lerman LO. Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease. Basic Res Cardiol 2020;115:16. [PMID: 31938859 DOI: 10.1007/s00395-019-0772-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
77 Callaghan BC, Reynolds EL, Banerjee M, Chant E, Villegas-Umana E, Gardner TW, Votruba K, Giordani B, Pop-Busui R, Pennathur S, Feldman EL. The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese. Diabetes Care. 2020;43:683-690. [PMID: 31932459 DOI: 10.2337/dc19-1642] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
78 Friedman AN. Implications and Management of Obesity in Kidney Disease. Nutrition in Kidney Disease 2020. [DOI: 10.1007/978-3-030-44858-5_12] [Reference Citation Analysis]
79 Murlidharan P, Kamaladevan S, Balan S, Kartha CC. Mechanisms for Obesity Related Kidney Disease. Pathophysiology of Obesity-Induced Health Complications 2020. [DOI: 10.1007/978-3-030-35358-2_12] [Reference Citation Analysis]
80 Afsharimoghaddam A. Prevalence of Metabolic Syndrome in Iranian Hemodialysis Patients: A Systematic Review and Meta-analysis. Int J Basic Sci Med 2019;4:131-136. [DOI: 10.34172/ijbsm.2019.02] [Reference Citation Analysis]
81 Stewart DJ, Langlois V, Noone D. Hyperuricemia and Hypertension: Links and Risks. Integr Blood Press Control 2019;12:43-62. [PMID: 31920373 DOI: 10.2147/IBPC.S184685] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
82 Cuadrado C, Dunstan J, Silva-Illanes N, Mirelman AJ, Nakamura R, Suhrcke M. Effects of a sugar-sweetened beverage tax on prices and affordability of soft drinks in Chile: A time series analysis. Soc Sci Med 2020;245:112708. [PMID: 31862547 DOI: 10.1016/j.socscimed.2019.112708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
83 King SE, Nilsson E, Beck D, Skinner MK. Adipocyte epigenetic alterations and potential therapeutic targets in transgenerationally inherited lean and obese phenotypes following ancestral exposures. Adipocyte 2019;8:362-78. [PMID: 31755359 DOI: 10.1080/21623945.2019.1693747] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
84 Biradar MI, Chiang KM, Yang HC, Huang YT, Pan WH. The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components. Int J Obes (Lond) 2020;44:865-74. [PMID: 31754239 DOI: 10.1038/s41366-019-0487-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
85 Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, Boucher R, Kimmel PL, Bress AP, Kramer HJ, Al-Marji C, Greene T, Beddhu S. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events. Am J Hypertens 2019;32:1170-7. [PMID: 31257407 DOI: 10.1093/ajh/hpz105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
86 Chen X, Bhuiyan I, Kuja-Halkola R, Magnusson PKE, Svensson P. Genetic and Environmental Influences on the Correlations between Traits of Metabolic Syndrome and CKD. Clin J Am Soc Nephrol 2019;14:1590-6. [PMID: 31506278 DOI: 10.2215/CJN.11971018] [Reference Citation Analysis]
87 Kramer H. Diet and Chronic Kidney Disease. Adv Nutr 2019;10:S367-79. [PMID: 31728497 DOI: 10.1093/advances/nmz011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
88 Yang Y. Metabolically Healthy Obesity and Risk of Incident Chronic Kidney Disease in a Korean Cohort Study. Iran J Public Health 2019;48:2007-15. [PMID: 31970099] [Reference Citation Analysis]
89 Wu Z, Jiang Y, Jia J, He D, Sun P, Li J, Huo Y, Fan F, Zhang Y. Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population. Diabetes Metab Syndr Obes 2019;12:2085-93. [PMID: 31632118 DOI: 10.2147/DMSO.S217326] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
90 Kawamoto R, Akase T, Ninomiya D, Kumagi T, Kikuchi A. Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese. Int Urol Nephrol 2019;51:2285-94. [PMID: 31642000 DOI: 10.1007/s11255-019-02320-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
91 Eirin A, Lerman LO. Stem cell-derived extracellular vesicles for renal repair: do cardiovascular comorbidities matter? Am J Physiol Renal Physiol 2019;317:F1414-9. [PMID: 31630544 DOI: 10.1152/ajprenal.00434.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Kiapidou S, Liava C, Kalogirou M, Akriviadis E, Sinakos E. Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? Ann Hepatol 2020;19:134-44. [PMID: 31606352 DOI: 10.1016/j.aohep.2019.07.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
93 Olivo RE, Davenport CA, Diamantidis CJ, Bhavsar NA, Tyson CC, Hall R, Bidulescu A, Young B, Mwasongwe SE, Pendergast J, Boulware LE, Scialla JJ. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant 2018;33:992-1001. [PMID: 28992354 DOI: 10.1093/ndt/gfx230] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
94 Gao RY, Hsu BG, Wu DA, Hou JS, Chen MC. Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes. Int J Endocrinol 2019;2019:5163245. [PMID: 31582974 DOI: 10.1155/2019/5163245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
95 Kim S, Uhm JY. Individual and Environmental Factors Associated with Proteinuria in Korean Children: A Multilevel Analysis. Int J Environ Res Public Health 2019;16:E3317. [PMID: 31505832 DOI: 10.3390/ijerph16183317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
96 Rangel Silvares R, Nunes Goulart da Silva Pereira E, Eduardo Ilaquita Flores E, Lino Rodrigues K, Ribeiro Silva A, Gonçalves-de-Albuquerque CF, Daliry A. High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense. Diabetes Metab Syndr Obes 2019;12:1773-81. [PMID: 31564943 DOI: 10.2147/DMSO.S211253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
97 Zeng H, Luo M, Li Z, Wen J, He G, Jin Y, Fu W, Zhou P. Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis. BMJ Open 2019;9:e029426. [PMID: 31352420 DOI: 10.1136/bmjopen-2019-029426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 King SE, McBirney M, Beck D, Sadler-Riggleman I, Nilsson E, Skinner MK. Sperm epimutation biomarkers of obesity and pathologies following DDT induced epigenetic transgenerational inheritance of disease. Environ Epigenet 2019;5:dvz008. [PMID: 31186947 DOI: 10.1093/eep/dvz008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
99 AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH. Prevalence of metabolic syndrome in dialysis and transplant patients. Diabetes Metab Syndr Obes 2019;12:575-9. [PMID: 31118720 DOI: 10.2147/DMSO.S200362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
100 Vieira MB, Neves JS, Leitão L, Baptista RB, Magriço R, Dias CV, Oliveira A, Carvalho D, Mc Causland FR. Impaired Fasting Glucose and Chronic Kidney Disease, Albuminuria, or Worsening Kidney Function: a Secondary Analysis of the SPRINT. J Clin Endocrinol Metab 2019:jc. [PMID: 31063197 DOI: 10.1210/jc.2019-00073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
101 Zhang LH, Zhu XY, Eirin A, Nargesi AA, Woollard JR, Santelli A, Sun IO, Textor SC, Lerman LO. Early podocyte injury and elevated levels of urinary podocyte-derived extracellular vesicles in swine with metabolic syndrome: role of podocyte mitochondria. Am J Physiol Renal Physiol 2019;317:F12-22. [PMID: 31042059 DOI: 10.1152/ajprenal.00399.2018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
102 Liu HW, Liu JS, Kuo KL. Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan. Ci Ji Yi Xue Za Zhi 2020;32:65-9. [PMID: 32110523 DOI: 10.4103/tcmj.tcmj_233_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
103 Bellini MI, Paoletti F, Herbert PE. Obesity and bariatric intervention in patients with chronic renal disease. J Int Med Res 2019;47:2326-41. [PMID: 31006298 DOI: 10.1177/0300060519843755] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
104 Moriyama T. Clinical and histological features and therapeutic strategies for IgA nephropathy. Clin Exp Nephrol 2019;23:1089-99. [PMID: 30968243 DOI: 10.1007/s10157-019-01735-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
105 Kim HJ, Lee J, Chae DW, Lee KB, Sung SA, Yoo TH, Han SH, Ahn C, Oh KH. Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study. BMC Nephrol 2019;20:119. [PMID: 30943913 DOI: 10.1186/s12882-019-1297-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
106 Kim MS, Shin KA. Serum Uric Acid to Creatinine Ratio as a Predictor of Metabolic Syndrome in Healthy Adults Men. Korean J Clin Lab Sci 2019;51:42-49. [DOI: 10.15324/kjcls.2019.51.1.42] [Reference Citation Analysis]
107 Raikou VD, Gavriil S. Body-mass index and the risk of albuminuria in hypertensive patients with a poor estimated glomerular filtration rate and the potential role of diabetes mellitus. Diabetes Metab Syndr 2019;13:1041-6. [PMID: 31336441 DOI: 10.1016/j.dsx.2019.01.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Bakhshayeshkaram M, Roozbeh J, Heidari ST, Honarvar B, Dabbaghmanesh MH, B Lankarani K. Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran. Int J Endocrinol Metab 2019;17:e81822. [PMID: 31372168 DOI: 10.5812/ijem.81822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
109 Welty FK. New Areas of Interest: Is There a Role for Omega-3 Fatty Acid Supplementation in Patients With Diabetes and Cardiovascular Disease? Curr Diab Rep 2019;19:6. [PMID: 30684085 DOI: 10.1007/s11892-019-1126-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Park KS, Kang EW. Is only fixed positive airway pressure a robust tool for kidney protection in patients with obstructive sleep apnea? J Thorac Dis 2018;10:S3819-23. [PMID: 30631487 DOI: 10.21037/jtd.2018.10.91] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
111 Porrini E, Navarro-díaz M, Rodríguez-rodríguez R, Salido E. Renal Disease in Obesity, Metabolic Syndrome and Diabesity. Diabetic Nephropathy 2019. [DOI: 10.1007/978-3-319-93521-8_5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Kohda Y, Matsumura H. Obesity-related hypertension and enhanced plasma orexin-A level are attenuated by the consumption of thiamine water in diabetic rats under cerebral oxidative stress conditions. Fundam Toxicol Sci 2019;6:383-390. [DOI: 10.2131/fts.6.383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Shin S, Srivastava A, Alli NA, Bandyopadhyay BC. Confounding risk factors and preventative measures driving nephrolithiasis global makeup. World J Nephrol 2018; 7(7): 129-142 [PMID: 30510912 DOI: 10.5527/wjn.v7.i7.129] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
114 Cai C, Mai Z, Deng T, Zhao Z, Zhu W, Wen Y, Duan X, Wu W, Zeng G. Impact of dyslipidemia on 24-h urine composition in adults without urolithiasis. Lipids Health Dis 2018;17:250. [PMID: 30400932 DOI: 10.1186/s12944-018-0899-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
115 Hosseini-Esfahani F, Bahadoran Z, Moslehi N, Asghari G, Yuzbashian E, Hosseinpour-Niazi S, Mirmiran P, Azizi F. Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab 2018;16:e84771. [PMID: 30584438 DOI: 10.5812/ijem.84771] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
116 Ho SP, Chen L, Allen FI, Hsi RS, Shimotake AR, Wiener SV, Kang M, Minor AM, Stoller ML. Architecture-Guided Fluid Flow Directs Renal Biomineralization. Sci Rep 2018;8:14157. [PMID: 30242165 DOI: 10.1038/s41598-018-30717-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
117 Ruiz-garcía A, Arranz-martínez E, García-álvarez JC, Morales-cobos LE, García-fernández ME, de la Peña-antón N, Martín Calle MC, Díez Pérez MC, Montero Costa A, Palacios Martínez D, García Villasur MP, García Granado MD, Lorenzo Borda MS, Cique Herráinz JA, Marañón Henrich N, Zarzuelo Martín N, Baltuille Aller MDC, Casaseca Calvo TF, Arribas Álvaro P, Macho del Barrio AI, Moreno Fernández JC, Ribot Catalá C, Capitán Caldas M, Ciria de Pablo C, Sanz Velasco C, Simonaggio Stancampiano P, Vargas-machuca Cabañero C, Sarriá Sánchez MT, Gómez Díaz E, Sanz Pozo B, Rodríguez de Mingo E, Cabello Igual MP, Rico Pérez MR, Migueláñez Valero A, Alcaraz Bethencourt A, Zafra Urango C, Chao Escuer P, Redondo de Pedro S, Escamilla Guijarro N, López Uriarte B, Rivera Teijido M. Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases. Clínica e Investigación en Arteriosclerosis (English Edition) 2018;30:197-208. [DOI: 10.1016/j.artere.2018.08.001] [Reference Citation Analysis]
118 Önerli Salman D, Şıklar Z, Çullas İlarslan EN, Özçakar ZB, Kocaay P, Berberoğlu M. Evaluation of Renal Function in Obese Children and Adolescents Using Serum Cystatin C Levels, Estimated Glomerular Filtration Rate Formulae and Proteinuria: Which is most Useful? J Clin Res Pediatr Endocrinol 2019;11:46-54. [PMID: 30145854 DOI: 10.4274/jcrpe.galenos.2018.2018.0046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
119 Birarra MK, Gelayee DA. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study. BMC Cardiovasc Disord 2018;18:149. [PMID: 30016936 DOI: 10.1186/s12872-018-0880-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
120 Eirin A, Hedayat AF, Ferguson CM, Textor SC, Lerman A, Lerman LO. Mitoprotection preserves the renal vasculature in porcine metabolic syndrome. Exp Physiol 2018;103:1020-9. [PMID: 29714040 DOI: 10.1113/EP086988] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
121 Choi I, Moon H, Kang SY, Ko H, Shin J, Lee J. The Risk of Microalbuminuria by Obesity Phenotypes according to Metabolic Health and Obesity: The Korean National Health and Nutrition Examination Survey 2011-2014. Korean J Fam Med 2018;39:168-73. [PMID: 29788705 DOI: 10.4082/kjfm.2018.39.3.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Zitt E, Pscheidt C, Concin H, Kramar R, Peter RS, Beyersmann J, Lhotta K, Nagel G. Long-term risk for end-stage kidney disease and death in a large population-based cohort. Sci Rep 2018;8:7729. [PMID: 29769597 DOI: 10.1038/s41598-018-26087-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
123 Kittiskulnam P, Thokanit NS, Katavetin P, Susanthitaphong P, Srisawat N, Praditpornsilpa K, Tungsanga K, Eiam-Ong S. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study. PLoS One 2018;13:e0196332. [PMID: 29742114 DOI: 10.1371/journal.pone.0196332] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
124 Xie F, Chan JC, Ma RC. Precision medicine in diabetes prevention, classification and management. J Diabetes Investig 2018;9:998-1015. [PMID: 29499103 DOI: 10.1111/jdi.12830] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
125 DeBoer MD, Filipp SL, Musani SK, Sims M, Okusa MD, Gurka M. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study. Kidney Blood Press Res 2018;43:555-67. [PMID: 29642060 DOI: 10.1159/000488829] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
126 Zhang J, Jiang H, Chen J. Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis. Oncotarget 2017;8:35619-29. [PMID: 27579531 DOI: 10.18632/oncotarget.10915] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
127 Chang AR, Surapaneni A, Kirchner HL, Young A, Kramer HJ, Carey DJ, Appel LJ, Grams ME. Metabolically Healthy Obesity and Risk of Kidney Function Decline. Obesity (Silver Spring) 2018;26:762-8. [PMID: 29498223 DOI: 10.1002/oby.22134] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
128 Li CC, Chien TM, Wu WJ, Huang CN, Chou YH. Uric acid stones increase the risk of chronic kidney disease. Urolithiasis 2018;46:543-7. [PMID: 29492591 DOI: 10.1007/s00240-018-1050-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
129 Kim H, Kim H, Lee M, Cha MU, Nam KH, An SY, Jung SY, Jhee JH, Park S, Yun HR, Kee YK, Oh HJ, Park JT, Chang TI, Yoo TH, Kang SW, Han SH. The impact of disease severity on paradoxical association between body mass index and mortality in patients with acute kidney injury undergoing continuous renal replacement therapy. BMC Nephrol 2018;19:32. [PMID: 29415663 DOI: 10.1186/s12882-018-0833-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
130 Raikou VD, Gavriil S. Metabolic Syndrome and Chronic Renal Disease. Diseases 2018;6:E12. [PMID: 29364162 DOI: 10.3390/diseases6010012] [Reference Citation Analysis]
131 Raikou VD, Gavriil S. Metabolic Syndrome and Chronic Renal Disease. Diseases 2018;6:E12. [PMID: 29364162 DOI: 10.3390/diseases6010012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
132 Simonson DC. Insulin Resistance and the Metabolic Syndrome in Chronic Renal Disease. Textbook of Nephro-Endocrinology 2018. [DOI: 10.1016/b978-0-12-803247-3.00015-5] [Reference Citation Analysis]
133 Brophy PD, Charlton JR, Bryan Carmody J, Reidy KJ, Harshman L, Segar J, Askenazi D, Shoham D, Bagby SP. Chronic Kidney Disease: A Life Course Health Development Perspective. Handbook of Life Course Health Development 2018. [DOI: 10.1007/978-3-319-47143-3_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
134 Fiori CZ, Martinez D, Carissimi A. Obesity and Comorbidities. Mechanical Ventilation in the Critically Ill Obese Patient 2018. [DOI: 10.1007/978-3-319-49253-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
135 Al-Daghri NM, Al-Attas OS, Wani K, Sabico S, Alokail MS. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. Sci Rep 2017;7:12104. [PMID: 28935934 DOI: 10.1038/s41598-017-12085-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
136 Kurata M, Takenouchi A, Tsuboi A, Minato S, Takeuchi M, Kitaoka K, Fukuo K, Kazumi T. The Cluster of Abnormalities Related to Metabolic Syndrome Is Associated With Reduced Glomerular Filtration Rate and Raised Albuminuria in Patients With Type 2 Diabetes Mellitus. J Clin Med Res 2017;9:759-64. [PMID: 28811852 DOI: 10.14740/jocmr3097w] [Reference Citation Analysis]
137 Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C. The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis. PLoS One 2017;12:e0182136. [PMID: 28759644 DOI: 10.1371/journal.pone.0182136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
138 Gallibois CM, Jawa NA, Noone DG. Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renovasc Dis 2017;10:205-13. [PMID: 28794651 DOI: 10.2147/IJNRD.S100891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
139 Elajami TK, Alfaddagh A, Lakshminarayan D, Soliman M, Chandnani M, Welty FK. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. J Am Heart Assoc 2017;6:e004740. [PMID: 28710178 DOI: 10.1161/JAHA.116.004740] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
140 Lew QJ, Jafar TH, Talaei M, Jin A, Chow KY, Yuan JM, Koh WP. Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. Kidney Int 2017;92:979-87. [PMID: 28528130 DOI: 10.1016/j.kint.2017.03.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
141 Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S, Pontremoli R; AMD-Annals Study Group. Metabolic syndrome, serum uric acid and renal risk in patients with T2D. PLoS One 2017;12:e0176058. [PMID: 28423036 DOI: 10.1371/journal.pone.0176058] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
142 Kuma A, Uchino B, Ochiai Y, Kawashima M, Enta K, Tamura M, Otsuji Y, Kato A. Impact of low-density lipoprotein cholesterol on decline in estimated glomerular filtration rate in apparently healthy young to middle-aged working men. Clin Exp Nephrol 2018;22:15-27. [PMID: 28386655 DOI: 10.1007/s10157-017-1407-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
143 Tanaka T, Hatakeyama S, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C. Clinical relevance of aortic calcification in urolithiasis patients. BMC Urol 2017;17:25. [PMID: 28376750 DOI: 10.1186/s12894-017-0218-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
144 Flores Rico SG, Mancilla Urrea E, Rodríguez Castellanos FE. Kidney function and metabolic variables before and after nephrectomy in kidney donors with or without overweight and obesity. Nefrología Latinoamericana 2017;14:63-8. [DOI: 10.1016/j.nefrol.2017.04.001] [Reference Citation Analysis]
145 Kim H, Kim J, Seo C, Lee M, Cha MU, Jung SY, Jhee JH, Park S, Yun HR, Kee YK, Yoon CY, Oh HJ, Park JT, Chang TI, Yoo TH, Kang SW, Han SH. Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy. Kidney Res Clin Pract 2017;36:39-47. [PMID: 28392996 DOI: 10.23876/j.krcp.2017.36.1.39] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
146 Almomen SM, Guan Q, Liang P, Yang K, Sidiqi AM, Levin A, Du C. Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats. Nutrients 2017;9:E345. [PMID: 28362355 DOI: 10.3390/nu9040345] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
147 Lee K. Lung function and impaired kidney function in relation to metabolic syndrome. Int Urol Nephrol 2017;49:1217-23. [PMID: 28299524 DOI: 10.1007/s11255-017-1567-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
148 Eirin A, Woollard JR, Ferguson CM, Jordan KL, Tang H, Textor SC, Lerman A, Lerman LO. The metabolic syndrome induces early changes in the swine renal medullary mitochondria. Transl Res 2017;184:45-56.e9. [PMID: 28363084 DOI: 10.1016/j.trsl.2017.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
149 Wang WH, Chen LW, Lee CC, Sun CY, Shyu YC, Hsu HR, Chien RN, Wu IW. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study. Biomed Res Int 2017;2017:7435657. [PMID: 28367447 DOI: 10.1155/2017/7435657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
150 Liu X, Luo X, Liu Y, Sun X, Han C, Zhang L, Wang B, Ren Y, Zhao Y, Zhang D, Hu D, Zhang M. Resting heart rate and risk of metabolic syndrome in adults: a dose-response meta-analysis of observational studies. Acta Diabetol 2017;54:223-35. [PMID: 27885415 DOI: 10.1007/s00592-016-0942-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
151 Oh IH, Choi JW, Lee CH, Park JS. Estimating Negative Effect of Abdominal Obesity on Mildly Decreased Kidney Function Using a Novel Index of Body-Fat Distribution. J Korean Med Sci 2017;32:613-20. [PMID: 28244287 DOI: 10.3346/jkms.2017.32.4.613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
152 Wang XX, Levi J, Luo Y, Myakala K, Herman-Edelstein M, Qiu L, Wang D, Peng Y, Grenz A, Lucia S, Dobrinskikh E, D'Agati VD, Koepsell H, Kopp JB, Rosenberg AZ, Levi M. SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE. J Biol Chem 2017;292:5335-48. [PMID: 28196866 DOI: 10.1074/jbc.M117.779520] [Cited by in Crossref: 171] [Cited by in F6Publishing: 178] [Article Influence: 34.2] [Reference Citation Analysis]
153 Bobe G, Cobb TJ, Leonard SW, Aponso S, Bahro CB, Koley D, Mah E, Bruno RS, Traber MG. Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome. Redox Biol 2017;12:121-8. [PMID: 28222379 DOI: 10.1016/j.redox.2017.02.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
154 Mahmoodnia L, Tamadon MR. On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease. J Nephropathol 2017;6:105-9. [PMID: 28975087 DOI: 10.15171/jnp.2017.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
155 Li JC, Wu DA, Hou JS, Subeq YM, Chen HD, Hsu BG. High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes. J Diabetes Res 2016;2016:8380279. [PMID: 28042581 DOI: 10.1155/2016/8380279] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
156 Mani NS, Ginier E. An Evidence-Based Approach to Conducting Systematic Reviews on CKD. Adv Chronic Kidney Dis 2016;23:355-62. [PMID: 28115078 DOI: 10.1053/j.ackd.2016.11.009] [Reference Citation Analysis]
157 Momoki K, Kataoka H, Moriyama T, Mochizuki T, Nitta K. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. J Atheroscler Thromb 2017;24:630-42. [PMID: 27784849 DOI: 10.5551/jat.37523] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
158 Zheng W, Qian G, Hao W, Geng X, Hong Q, Cai G, Chen X, Wu D. Cardiovascular metabolic risk factors and glomerular filtration rate: a rural Chinese population study. Lipids Health Dis 2016;15:180. [PMID: 27733200 DOI: 10.1186/s12944-016-0346-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
159 Mukendi K, Lepira FB, Makulo JR, Sumaili KE, Kayembe PK, Nseka MN. Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study. Cardiovasc J Afr 2015;26:125-9. [PMID: 26592908 DOI: 10.5830/CVJA-2014-076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
160 Zitt E, Pscheidt C, Concin H, Kramar R, Lhotta K, Nagel G. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria. PLoS One 2016;11:e0161376. [PMID: 27537361 DOI: 10.1371/journal.pone.0161376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
161 Lizardo ME, Navarro MDP, Camacho M, Magallanes-hernández MA, Pacheco-gutiérrez RG, López-bordones M, Cabello R, González-mayo G, Vicci H, Dorta L. Estimación de la tasa de filtración glomerular en personas con y sin síndrome metabólico. Rev Fac Cienc Salud UDES 2016;3:22. [DOI: 10.20320/rfcsudes.v3i1.102] [Reference Citation Analysis]
162 Cohen JB, Stephens-Shields AJ, Denburg MR, Anderson AH, Townsend RR, Reese PP. Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study. Am J Nephrol 2016;43:431-40. [PMID: 27228992 DOI: 10.1159/000446862] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
163 Yu S, Yang H, Guo X, Zheng L, Sun Y. Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China. Int J Environ Res Public Health 2016;13:E540. [PMID: 27240390 DOI: 10.3390/ijerph13060540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
164 Sarathy H, Henriquez G, Abramowitz MK, Kramer H, Rosas SE, Johns T, Kumar J, Skversky A, Kaskel F, Melamed ML. Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010. PLoS One 2016;11:e0153588. [PMID: 27224643 DOI: 10.1371/journal.pone.0153588] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
165 Heianza Y, Hara S, Saito K, Tsuji H, Tanaka S, Kodama S, Kobayashi T, Arase Y, Sone H. Assessment of kidney dysfunction with cystatin C- and creatinine-based estimated glomerular filtration rate and predicting type 2 diabetes: Toranomon Hospital Health Management Center Study 21. Diabetes Res Clin Pract 2016;113:60-8. [PMID: 26972964 DOI: 10.1016/j.diabres.2016.01.026] [Reference Citation Analysis]
166 Redon J, Lurbe E. The kidney in obesity. Curr Hypertens Rep 2015;17:555. [PMID: 25893477 DOI: 10.1007/s11906-015-0555-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
167 Bouchi R, Ohara N, Asakawa M, Nakano Y, Takeuchi T, Murakami M, Sasahara Y, Numasawa M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? Cardiovasc Diabetol 2016;15:10. [PMID: 26790628 DOI: 10.1186/s12933-016-0335-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
168 William JH, Kramer H, Rosas SE. Kidney Disease in Obesity and Metabolic Syndrome. Metabolic Syndrome 2016. [DOI: 10.1007/978-3-319-11251-0_49] [Reference Citation Analysis]
169 Beamish AJ, Olbers T. The Role of Bariatric Surgery in the Management of Morbid Childhood Obesity. Curr Pediatr Rep 2015;3:259-266. [DOI: 10.1007/s40124-015-0092-x] [Reference Citation Analysis]
170 Kanda E, Muneyuki T, Suwa K, Nakajima K. Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort. PLoS One 2015;10:e0143434. [PMID: 26599331 DOI: 10.1371/journal.pone.0143434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
171 Maleki A, Montazeri M, Rashidi N, Montazeri M, Yousefi-Abdolmaleki E. Metabolic syndrome and its components associated with chronic kidney disease. J Res Med Sci 2015;20:465-9. [PMID: 26487875 DOI: 10.4103/1735-1995.163969] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
172 Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, Lucia S, Adorini L, D'Agati VD, Levi J, Rosenberg A, Kopp JB, Gius DR, Saleem MA, Levi M. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J Am Soc Nephrol 2016;27:1362-78. [PMID: 26424786 DOI: 10.1681/ASN.2014121271] [Cited by in Crossref: 82] [Cited by in F6Publishing: 91] [Article Influence: 11.7] [Reference Citation Analysis]
173 Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up. PLoS One 2015;10:e0135052. [PMID: 26322515 DOI: 10.1371/journal.pone.0135052] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
174 Gabbay E, Slotki I, Shavit L. Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease. BMC Nephrol 2015;16:133. [PMID: 26249332 DOI: 10.1186/s12882-015-0137-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
175 Kanda E, Muneyuki T, Suwa K, Nakajima K. Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study. PLoS One 2015;10:e0134937. [PMID: 26237314 DOI: 10.1371/journal.pone.0134937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
176 Hong D, Zhang Y, Gao B, Wang J, Li G, Wang L, Zhang L; China National Survey of CKD Working Group. Metabolic Syndrome without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study. PLoS One 2015;10:e0132220. [PMID: 26161991 DOI: 10.1371/journal.pone.0132220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
177 Biino G, Concas MP, Cena H, Parracciani D, Vaccargiu S, Cosso M, Marras F, D'Esposito V, Beguinot F, Pirastu M. Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. Springerplus 2015;4:324. [PMID: 26180744 DOI: 10.1186/s40064-015-1049-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
178 Cao X, Zhou J, Yuan H, Wu L, Chen Z. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort. BMC Nephrol 2015;16:85. [PMID: 26084279 DOI: 10.1186/s12882-015-0083-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
179 Salinero-Fort MA, San Andrés-Rebollo FJ, de Burgos-Lunar C, Gómez-Campelo P, Chico-Moraleja RM, López de Andrés A, Jiménez-García R; MADIABETES Group. Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study. PLoS One 2015;10:e0122030. [PMID: 25856231 DOI: 10.1371/journal.pone.0122030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
180 Lee HO, Bak HJ, Shin JY, Song YM. Association between Metabolic Syndrome and Microalbuminuria in Korean Adults. Korean J Fam Med 2015;36:60-71. [PMID: 25802687 DOI: 10.4082/kjfm.2015.36.2.60] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
181 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 258] [Article Influence: 34.7] [Reference Citation Analysis]
182 Song YM, Sung J, Lee K. Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study. Clin Exp Nephrol 2015;19:887-94. [PMID: 25634252 DOI: 10.1007/s10157-015-1083-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
183 Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, Yamazaki M, Oda Y, Hasegawa G, Toda H, Nakamura N, Fukui M. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol 2015;10:578-83. [PMID: 25635035 DOI: 10.2215/CJN.08980914] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 14.7] [Reference Citation Analysis]
184 Muntner P, Levin A. Epidemiology of Chronic Kidney Disease. Chronic Renal Disease 2015. [DOI: 10.1016/b978-0-12-411602-3.00006-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
185 Bajraktarova Prosheva T. The Role of Metabolic Syndrome in the Development and Progression of Chronic Renal Failure. Maced Med Electr J 2015. [DOI: 10.3889/mmej.2015.50005] [Reference Citation Analysis]
186 Rosas SE, William JH, Kramer H. Kidney Disease in Obesity and Metabolic Syndrome. Metabolic Syndrome 2015. [DOI: 10.1007/978-3-319-12125-3_49-1] [Reference Citation Analysis]
187 William JH, Kramer H, Rosas SE. Kidney Disease in Obesity and Metabolic Syndrome. Metabolic Syndrome 2015. [DOI: 10.1007/978-3-319-12125-3_49-2] [Reference Citation Analysis]
188 Ohno I. IV. Uric Acid Metabolic Disorder (Relationship between Hyperuricemia and CKD・CVD). J Jpn Soc Intern Med 2015;104:931-937. [DOI: 10.2169/naika.104.931] [Reference Citation Analysis]
189 Franceschini N, Gouskova NA, Reiner AP, Bostom A, Howard BV, Pettinger M, Umans JG, Brookhart MA, Winkelmayer WC, Eaton CB, Heiss G, Fine JP. Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol 2015;10:241-50. [PMID: 25452225 DOI: 10.2215/CJN.02860314] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
190 Song H, Wang X, Cai Q, Ding W, Huang S, Zhuo L. Association of metabolic syndrome with decreased glomerular filtration rate among 75,468 Chinese adults: a cross-sectional study. PLoS One 2014;9:e113450. [PMID: 25415451 DOI: 10.1371/journal.pone.0113450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
191 Prasad GVR. Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol 2014; 3(4): 210-219 [PMID: 25374814 DOI: 10.5527/wjn.v3.i4.210] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 84] [Article Influence: 10.1] [Reference Citation Analysis]
192 Nair AR, Elks CM, Vila J, Del Piero F, Paulsen DB, Francis J. A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway. PLoS One 2014;9:e111976. [PMID: 25372283 DOI: 10.1371/journal.pone.0111976] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
193 Handa RK, Johnson CD, Connors BA, Evan AP, Phillips CL, Liu Z. Shock wave lithotripsy does not impair renal function in a Swine model of metabolic syndrome. J Endourol 2015;29:468-73. [PMID: 25285417 DOI: 10.1089/end.2014.0570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
194 Nashar K, Egan BM. Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes Metab Syndr Obes 2014;7:421-35. [PMID: 25258547 DOI: 10.2147/DMSO.S45183] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
195 Garland JS. Elevated body mass index as a risk factor for chronic kidney disease: current perspectives. Diabetes Metab Syndr Obes 2014;7:347-55. [PMID: 25114577 DOI: 10.2147/DMSO.S46674] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
196 Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122. [PMID: 25064611 DOI: 10.1186/1471-2369-15-122] [Cited by in Crossref: 199] [Cited by in F6Publishing: 209] [Article Influence: 24.9] [Reference Citation Analysis]
197 Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagström H, Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Hafliðadóttir S, Björnsson ES, Armstrong MJ, Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M, Haring R, Lerch MM, Rettig R, Völzke H, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 2014;11:e1001680. [PMID: 25050550 DOI: 10.1371/journal.pmed.1001680] [Cited by in Crossref: 380] [Cited by in F6Publishing: 408] [Article Influence: 47.5] [Reference Citation Analysis]
198 Charles LE, Gu JK, Fekedulegn D, Andrew ME, Violanti JM, Burchfiel CM. Association between shiftwork and glomerular filtration rate in police officers. J Occup Environ Med 2013;55:1323-8. [PMID: 24164760 DOI: 10.1097/JOM.0b013e3182a299c9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
199 Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol 2014;15:108. [PMID: 25005601 DOI: 10.1186/1471-2369-15-108] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
200 Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, Bhuiyan AR, Jenkins BC, Addison C. The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study. PLoS One 2014;9:e101610. [PMID: 24991817 DOI: 10.1371/journal.pone.0101610] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
201 McMahon GM, Preis SR, Hwang SJ, Fox CS. Mid-adulthood risk factor profiles for CKD. J Am Soc Nephrol 2014;25:2633-41. [PMID: 24970884 DOI: 10.1681/ASN.2013070750] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
202 Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3:208-220. [PMID: 24454316 DOI: 10.1159/000355405] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 14.1] [Reference Citation Analysis]
203 Schwingshackl L, Hoffmann G. Comparison of high vs. normal/low protein diets on renal function in subjects without chronic kidney disease: a systematic review and meta-analysis. PLoS One 2014;9:e97656. [PMID: 24852037 DOI: 10.1371/journal.pone.0097656] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 8.4] [Reference Citation Analysis]
204 Kang YU, Kim HY, Choi JS, Kim CS, Bae EH, Ma SK, Kim SW. Metabolic syndrome and chronic kidney disease in an adult Korean population: results from the Korean National Health Screening. PLoS One 2014;9:e93795. [PMID: 24807226 DOI: 10.1371/journal.pone.0093795] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
205 Kumar PA, Chitra PS, Reddy GB. Metabolic syndrome and associated chronic kidney diseases: nutritional interventions. Rev Endocr Metab Disord 2013;14:273-86. [PMID: 24036690 DOI: 10.1007/s11154-013-9268-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
206 Kose E, An T, Kikkawa A, Matsumoto Y, Hayashi H. Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization. Clin Pharmacol 2014;6:71-8. [PMID: 24748823 DOI: 10.2147/CPAA.S57442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
207 Rendina D, De Filippo G, D'Elia L, Strazzullo P. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol 2014;27:371-6. [PMID: 24696310 DOI: 10.1007/s40620-014-0085-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
208 Jang CM, Hyun YY, Lee KB, Kim H. Insulin resistance is associated with the development of albuminuria in Korean subjects without diabetes. Endocrine 2015;48:203-10. [PMID: 24676759 DOI: 10.1007/s12020-014-0242-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
209 Orlić L, Mikolasevic I, Bagic Z, Racki S, Stimac D, Milic S. Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link? Gastroenterol Res Pract 2014;2014:847539. [PMID: 24729784 DOI: 10.1155/2014/847539] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
210 Szeto CC, Kwan BC, Chow KM, Leung CB, Cheng MS, Law MC, Li PK. Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications. Clin J Am Soc Nephrol 2014;9:779-87. [PMID: 24458080 DOI: 10.2215/CJN.06620613] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
211 Friedman AN. Implications and Management of Obesity in Kidney Disease. Nutrition in Kidney Disease 2014. [DOI: 10.1007/978-1-62703-685-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
212 El-Eshmawy MM, Abd El-Hafez HA, El Shabrawy WO, Abdel Aal IA. Subclinical hypothyroidism is independently associated with microalbuminuria in a cohort of prediabetic egyptian adults. Diabetes Metab J 2013;37:450-7. [PMID: 24404516 DOI: 10.4093/dmj.2013.37.6.450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
213 Athyros V, Reklou A, Lazarides A, Mitsiou E, Karagiannis A. Effect of Cardio-Metabolic Risk Factors Clustering with or without Arterial Hypertension on Arterial Stiffness: A Narrative Review. Diseases 2013;1:51-72. [DOI: 10.3390/diseases1010051] [Reference Citation Analysis]
214 Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM. Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis 2013;12:159. [PMID: 24164719 DOI: 10.1186/1476-511X-12-159] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 10.8] [Reference Citation Analysis]
215 Conlin M, Tadros N. Patient Selection and Informed Consent. Percutaneous Renal Surgery 2013. [DOI: 10.1002/9781118670903.ch20] [Reference Citation Analysis]
216 Onat A, Aydın M, Can G, Çakmak HA, Köroğlu B, Kaya A, Ademoğlu E. Impaired fasting glucose: Pro-diabetic, “atheroprotective” and modified by metabolic syndrome. World J Diabetes 2013; 4(5): 210-218 [PMID: 24147205 DOI: 10.4239/wjd.v4.i5.210] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
217 Azushima K, Tamura K, Wakui H, Maeda A, Ohsawa M, Uneda K, Kobayashi R, Kanaoka T, Dejima T, Fujikawa T, Yamashita A, Toya Y, Umemura S. Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity. PLoS One 2013;8:e75560. [PMID: 24130717 DOI: 10.1371/journal.pone.0075560] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
218 Zhang AD, Dai SX, Huang JF. Reconstruction and analysis of human kidney-specific metabolic network based on omics data. Biomed Res Int. 2013;2013:187509. [PMID: 24222897 DOI: 10.1155/2013/187509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
219 Nagel G, Zitt E, Peter R, Pompella A, Concin H, Lhotta K. Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population. BMC Nephrol 2013;14:177. [PMID: 23962027 DOI: 10.1186/1471-2369-14-177] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
220 Nigwekar SU, Thadhani RI. Shining light on vitamin D trials in chronic kidney disease. Kidney Int 2013;83:198-200. [PMID: 23364588 DOI: 10.1038/ki.2012.415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
221 Angle BM, Do RP, Ponzi D, Stahlhut RW, Drury BE, Nagel SC, Welshons WV, Besch-Williford CL, Palanza P, Parmigiani S. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol. 2013;42:256-268. [PMID: 23892310 DOI: 10.1016/j.reprotox.2013.07.017] [Cited by in Crossref: 201] [Cited by in F6Publishing: 211] [Article Influence: 22.3] [Reference Citation Analysis]
222 Leung RK, Wang Y, Ma RC, Luk AO, Lam V, Ng M, So WY, Tsui SK, Chan JC. Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis. BMC Nephrol 2013;14:162. [PMID: 23879411 DOI: 10.1186/1471-2369-14-162] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
223 Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant 2013;13:2342-51. [PMID: 23865821 DOI: 10.1111/ajt.12369] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
224 Litwin M, Niemirska A. Metabolic syndrome in children with chronic kidney disease and after renal transplantation. Pediatr Nephrol 2014;29:203-16. [PMID: 23760991 DOI: 10.1007/s00467-013-2500-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
225 Lee CC, Adler AI. Recent findings on the effects of marine-derived n-3 polyunsaturated fatty acids on urinary albumin excretion and renal function. Curr Atheroscler Rep 2012;14:535-41. [PMID: 22886495 DOI: 10.1007/s11883-012-0279-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
226 Hadigan C, Edwards E, Rosenberg A, Purdy JB, Fleischman E, Howard L, Mican JM, Sampath K, Oyalowo A, Johnson A, Adler A, Rehm C, Smith M, Lai L, Kopp JB. Microalbuminuria in HIV disease. Am J Nephrol 2013;37:443-51. [PMID: 23615312 DOI: 10.1159/000350384] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
227 Kebapci N, Uslu S, Ozcelik E. Metabolic Syndrome Is a Risk Factor for the Development of Chronic Renal Disease. Renal Failure 2013;35:460-5. [DOI: 10.3109/0886022x.2013.774680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
228 Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Morano S, Cavalot F, Lamacchia O, Laviola L. HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care. 2013;36:2301-2310. [PMID: 23491522 DOI: 10.2337/dc12-2264] [Cited by in Crossref: 109] [Cited by in F6Publishing: 113] [Article Influence: 12.1] [Reference Citation Analysis]
229 Karalius VP, Shoham DA. Dietary sugar and artificial sweetener intake and chronic kidney disease: a review. Adv Chronic Kidney Dis 2013;20:157-64. [PMID: 23439375 DOI: 10.1053/j.ackd.2012.12.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
230 Kim JK, Ju YS, Moon SJ, Song YR, Kim HJ, Kim SG. High pulse pressure and metabolic syndrome are associated with proteinuria in young adult women. BMC Nephrol 2013;14:45. [PMID: 23433013 DOI: 10.1186/1471-2369-14-45] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
231 Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013;8:945-952. [PMID: 23411425 DOI: 10.2215/cjn.09870912] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
232 Williams ME, Magerowski G, Blackburn GL. Nutritional and Metabolic Management of Obesity and the Metabolic Syndrome in the Patient with Chronic Kidney Disease. Nutritional Management of Renal Disease 2013. [DOI: 10.1016/b978-0-12-391934-2.00029-1] [Reference Citation Analysis]
233 Sirota JC, McFann K, Targher G, Chonchol M, Jalal DI. Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994. Am J Nephrol 2012;36:466-71. [PMID: 23128368 DOI: 10.1159/000343885] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
234 Kovács T, Vas T, Kovesdy CP, Késõi I, Sági B, Wittmann I, Nagy J. Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy. Clin Kidney J 2013;6:395-401. [PMID: 27293567 DOI: 10.1093/ckj/sfs131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
235 Brands MW, Manhiani MM. Sodium-retaining effect of insulin in diabetes. Am J Physiol Regul Integr Comp Physiol 2012;303:R1101-9. [PMID: 23034715 DOI: 10.1152/ajpregu.00390.2012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
236 Bandgar TR, Kalra S, Sahay M. Metabolic syndrome leading to chronic kidney disease: An emerging threat. Indian J Endocrinol Metab 2012;16:151-3. [PMID: 22470847 DOI: 10.4103/2230-8210.93728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
237 Tvarijonaviciute A, Ceron JJ, Holden SL, Cuthbertson DJ, Biourge V, Morris PJ, German AJ. Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome. BMC Vet Res 2012;8:147. [PMID: 22929809 DOI: 10.1186/1746-6148-8-147] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 7.9] [Reference Citation Analysis]
238 Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol 2012;2012:691369. [PMID: 22919275 DOI: 10.1155/2012/691369] [Cited by in Crossref: 45] [Cited by in F6Publishing: 67] [Article Influence: 4.5] [Reference Citation Analysis]
239 Kopp JB. Glomerular homeostasis requires a match between podocyte mass and metabolic load. J Am Soc Nephrol 2012;23:1273-5. [PMID: 22797185 DOI: 10.1681/ASN.2012060618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
240 Troppmann C. Pushing the limits in live kidney donation: can you ever be too old or too heavy to donate? Transplantation 2012;93:1092-3. [PMID: 22466788 DOI: 10.1097/TP.0b013e31824ef1f7] [Reference Citation Analysis]
241 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
242 De Caterina AR, Harper AR, Cuculi F. Critical evaluation of the efficacy and tolerability of azilsartan. Vasc Health Risk Manag 2012;8:299-305. [PMID: 22661897 DOI: 10.2147/VHRM.S22589] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
243 Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant 2012;27:3228-34. [PMID: 22553369 DOI: 10.1093/ndt/gfs058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
244 Slee AD. Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab (Lond) 2012;9:36. [PMID: 22537670 DOI: 10.1186/1743-7075-9-36] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
245 Woolston A, Tu YK, Baxter PD, Gilthorpe MS. A comparison of different approaches to unravel the latent structure within metabolic syndrome. PLoS One 2012;7:e34410. [PMID: 22485169 DOI: 10.1371/journal.pone.0034410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
246 Vlassara H, Uribarri J, Cai W, Goodman S, Pyzik R, Post J, Grosjean F, Woodward M, Striker GE. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clin J Am Soc Nephrol. 2012;7:934-942. [PMID: 22461535 DOI: 10.2215/cjn.12891211] [Cited by in Crossref: 107] [Cited by in F6Publishing: 110] [Article Influence: 10.7] [Reference Citation Analysis]
247 Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR, Schold JD. Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond) 2012;36:1585-90. [PMID: 22290538 DOI: 10.1038/ijo.2012.7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]